Novel immunotherapeutic target against hepatocellular carcinoma
Researchers have discovered the role of an isoformic programmed cell death protein 1 (PD-1) in suppressing the function of killer T cells, which is a type of immune cells essential for killing cancer cells among hepatocellular carcinoma (HCC) patients.
Materials provided by The University of Hong Kong. Note: Content may be edited for style and length.
Source link aaaaa